UPDATE: Due to the ongoing transition at the US Food and Drug Administration and pause on speaking engagements by FDA representatives, we have canceled this session of “Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development,” as PERI has several expert faculty who present at this course from the FDA.

The next session of this course will be held online in October 2025.

Course Description:
Therapeutics for cancer are entering a new era, where precision approaches promise to revolutionize the way in this disease is treated. This comprehensive course reviews current and emerging drugs, immunotherapies, their application to specific cancer types, how to conduct clinical trials for oncologic therapies, and the drug development process for drug candidates leading to their approval. The US Food & and Drug Administration (FDA) regulatory considerations for oncology drugs, registration endpoints, and accelerated and breakthrough approval mechanisms are also covered.

Course Prices:
Individual Course Registration: $1,795.00 USD
Early Individual Course Registration: $1,595.00 USD